GLP-1 medications have changed weight loss medicine in a way nothing has in decades. They work, the data is robust, and they're available right now. They're also widely misunderstood, marketed badly, prescribed irresponsibly in many places, and are not a magic bullet. This guide gives you the honest picture.
By the end you'll know what GLP-1s actually are, the difference between the major medications, what to expect from treatment, the side effects worth knowing about, and what we look for in a good candidate.
What is GLP-1?
GLP-1 (glucagon-like peptide-1) is a hormone your gut releases when you eat. It does several things at once: stimulates insulin release in response to food, suppresses glucagon (the hormone that raises blood sugar), slows the rate at which your stomach empties, and signals fullness to your brain. The net effect is better blood sugar control and reduced appetite.
Your body makes GLP-1 in small amounts that break down quickly. GLP-1 receptor agonists are medications that mimic GLP-1 but resist breakdown — so they stick around for days instead of minutes, producing a much stronger and more sustained effect.
The major GLP-1 medications
Brand-name GLP-1s have become household names, but they're not all the same. Here's what each one is.
Semaglutide
- Ozempic — FDA-approved for type 2 diabetes (weekly injection)
- Wegovy — FDA-approved for chronic weight management (weekly injection, higher max dose)
- Rybelsus — oral semaglutide for type 2 diabetes (daily pill)
Same molecule, different brands and indications. In clinical trials, semaglutide at the weight-loss dose produces an average of ~15% body weight loss at 68 weeks.
Tirzepatide
- Mounjaro — FDA-approved for type 2 diabetes (weekly injection)
- Zepbound — FDA-approved for chronic weight management (weekly injection)
Tirzepatide is a "dual agonist" — it activates both GLP-1 and GIP (another gut hormone) receptors. The dual mechanism produces somewhat stronger effects: ~20% average body weight loss at 72 weeks in trials.
Liraglutide
- Victoza — diabetes (daily injection)
- Saxenda — chronic weight management (daily injection)
Older GLP-1, requires daily dosing. Less convenient than the weekly options and modestly less effective. Still occasionally used.
Compounded semaglutide and tirzepatide
During shortages of brand-name medications, the FDA permitted compounding pharmacies to produce these molecules. Quality varies enormously by pharmacy. Some compounders are excellent; others are not. We only work with vetted, accredited compounding pharmacies and walk you through the differences.
Quick fact
The first GLP-1 medication (exenatide) was actually developed from Gila monster venom — the lizard's saliva contains a peptide that closely resembles human GLP-1, and it inspired the entire drug class.
What treatment looks like
A typical GLP-1 protocol follows a slow dose-escalation pattern over several months. This is critical — escalating too fast is the main reason patients quit due to side effects.
- Initial consult and labs. We confirm you're a candidate, screen for contraindications, and get baseline metabolic markers.
- Starting dose. Usually a low dose for 4 weeks. Most people feel modest appetite suppression and some early side effects that fade.
- Gradual escalation. Dose increases every 4 weeks (faster in some protocols, slower in others) based on tolerance and progress.
- Maintenance. Once at an effective dose, weight loss continues steadily over 6–18 months. Most patients hit a plateau eventually and either maintain at that dose, increase further, or switch medications.
- Long-term. Like blood pressure medication, GLP-1s tend to work as long as you take them. Stopping usually means partial weight regain unless major lifestyle changes are firmly in place.
Side effects and what to expect
The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, constipation, reflux, and bloating. They tend to be worse with each dose escalation and improve over the following weeks.
Practical strategies that genuinely help:
- Eat smaller, more frequent meals during dose escalation
- Avoid very fatty or very greasy foods
- Stay well hydrated; aim for at least 80–100 oz water daily
- Limit alcohol — it amplifies nausea and slows recovery
- Eat slowly; the satiety signaling is delayed, so you'll feel full later than you used to
Less common but worth knowing:
- Pancreatitis (rare): severe upper abdominal pain that radiates to the back. If this happens, stop the medication and seek evaluation.
- Gallstones: rapid weight loss of any kind raises gallstone risk. Symptoms warrant prompt evaluation.
- Muscle loss: significant weight loss without resistance training and adequate protein leads to muscle loss along with fat. We always emphasize protein intake (≥0.8 g per pound of goal body weight) and strength training.
- "Ozempic face": rapid fat loss in the face can look gaunt. This is a cosmetic concern, not a medical one, but it's real.
Who's a good candidate
GLP-1 medications make the most sense for:
- Adults with a BMI ≥30, or BMI ≥27 with weight-related comorbidities (type 2 diabetes, prediabetes, hypertension, sleep apnea, etc.)
- Patients who've tried and not sustained results from lifestyle changes alone
- Patients willing to commit to lifestyle changes alongside the medication, not as a substitute for them
- Patients who can afford the medication or have insurance coverage
Less ideal candidates:
- Anyone wanting to lose 10–15 pounds for vanity reasons — the side effects, cost, and indefinite duration aren't usually worth it for that range
- Patients with specific contraindications (see FAQ below)
- Anyone who can't or won't track basic metrics or attend follow-ups
Cost and insurance
Brand-name GLP-1s cost roughly $1,000–$1,400 per month at retail. Insurance coverage varies enormously: many plans cover them for type 2 diabetes (Ozempic, Mounjaro), fewer cover them for weight management (Wegovy, Zepbound). Compounded semaglutide and tirzepatide range from $200 to $500 per month depending on dose and pharmacy. We're transparent about pricing during the consultation and help you find the best path.
Frequently asked questions
How much weight can you lose on GLP-1 medications?
In clinical trials, semaglutide (Wegovy) produced an average weight loss of about 15% of body weight at 68 weeks, and tirzepatide (Zepbound) produced about 20% at 72 weeks. Real-world results vary depending on dose, adherence, lifestyle, and individual response.
What are the most common GLP-1 side effects?
The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, constipation, and reflux. They are usually mild to moderate and tend to improve within a few weeks. Slow dose escalation, smaller meals, and avoiding very fatty foods reduce these effects significantly.
Do you regain weight when you stop GLP-1 medications?
Most patients regain a substantial portion of lost weight within a year of stopping if no other changes are sustained. This is why we emphasize that GLP-1s are a tool, not a cure — they work best alongside durable changes to nutrition, training, and sleep that you can maintain long-term.
Who is not a candidate for GLP-1 medications?
GLP-1 medications are not recommended for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2), or those with a history of pancreatitis. Pregnancy and breastfeeding are contraindications. Active gallbladder disease and severe gastroparesis also warrant caution. A clinician will review your full medical history before prescribing.
What's next?
GLP-1 medications are a real, well-studied tool. They're not for everyone, and they work best as part of a broader plan that includes nutrition, strength training, and sleep. The right move is a consultation that looks at your full picture — and a treatment plan built around your goals, your situation, and your timeline.